Targeted lentiviral delivery for in vivo CAR T-cell generation

Targeted lentiviral delivery for in vivo CAR-T cell generation is an experimental approach to CAR-T cell therapy in which retargeted lentiviral vectors deliver a chimeric antigen receptor (CAR) transgene directly to endogenous T cells in the body, rather than modifying cells ex vivo and reinfusing them.